New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 8, 2013
11:07 EDTTEF, SKUL, STI, NVAX, PHigh option volume stocks: TEF SKUL STI NVAX P
News For TEF;SKUL;STI;NVAX;P From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 30, 2014
10:30 EDTNVAXJ&J could have considered Novavax, Achillion instead of Alios, TheStreet says
Subscribe for More Information
September 24, 2014
06:31 EDTNVAXNovavax price target raised to $10.50 from $9 at Piper Jaffray
Subscribe for More Information
September 23, 2014
13:09 EDTPJudge rules Sirius XM infringed copyrights by playing songs recorded pre-1972
In a $100M royalty lawsuit between the rock band The Turtles and Sirius XM (SIRI), a California federal judge ruled that Sirius XM infringed copyrights and violated California state laws by broadcasting songs recorded before 1972 without paying royalties for the performance of the recording. Judge Philip Gutierrez ruled that the music industry can claim additional copyright in broadcasted songs that were recorded before 1972. The ruling can have a far reaching impact on digital radio providers who may have to cough up additional royalty fees for playing songs recorded before 1972. Pandora (P) is also a digital radio provider. Reference Link
12:33 EDTNVAXNovavax strong data validates purchase of Isconova, says Ladenburg
Subscribe for More Information
11:42 EDTTEFTelefonica mulls range of tie-up options with Grupo Televisa, Reuters says
Subscribe for More Information
10:02 EDTPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:47 EDTNVAXNovavax announces BARDA exercise of contract option
Subscribe for More Information
08:41 EDTNVAXNovavax H7N9 vaccine candidate delivers positive Phase 1/2 clinical data
Novavax announced positive top-line data from a Phase 1/2 clinical trial of its H7N9 Avian Influenza VLP Vaccine Candidate, or H7N9 VLP, with proprietary adjuvant Matrix-M. This trial was conducted under the company's contract with HHS-BARDA for the development of VLPs to address influenza strains with pandemic potential. The H7N9 VLP, with and without Matrix-M, was well tolerated and demonstrated a safety profile similar to the company's prior experience with another saponin-based adjuvant. Matrix-M adjuvanted formulations demonstrated a clear immunogenicity benefit relative to unadjuvanted antigen, and a dose-response within the adjuvanted groups. Antigen dose-sparing was shown, such that even the 3.75µg dose of antigen with either tested dose of adjuvant gave immune responses statistically significantly greater than 15µg dose without adjuvant. Geometric mean titers of hemagglutination-inhibiting antibody after two vaccine doses were comparable to those reported in prior studies with another saponin adjuvant when similar antigen and adjuvant doses were compared. The vaccine also elicited anti-neuraminidase antibodies against N9, with 89 to 100% sero-response rates in the adjuvanted vaccine groups, and greater than 11-fold increases in geometric mean titers.
07:05 EDTPPandora initiated with a Hold at Topeka
Subscribe for More Information
September 22, 2014
12:02 EDTPPandora management to meet with Piper Jaffray
Subscribe for More Information
September 19, 2014
07:41 EDTNVAXNovavax coverage assumed with an Outperform at Wedbush
Subscribe for More Information
06:17 EDTTEFTelefonica acquires Brazil's GVT from Vivendi
Spanish telecom company Telefonica (TEF) agreed to buy Brazilian telecom unit Global Village Telecom, or GVT, from Vivendi (VIVHY) for EUR4.66B in cash as well as a payment in shares representing 12.0% of the share capital of Telefonica Brasil, after its integration with GVT. As part of the agreement, Vivendi has accepted Telefonica’s offer to acquire 1.1B ordinary shares held by Telefonica in Telecom Italia (TI), currently representing 8.3% of Telecom Italia’s voting share capital (corresponding to 5.7% of its total share capital), in exchange of 4.5% of Vivendi’s capital in the company resulting from the integration between Telefonica Brasil and GVT.
September 18, 2014
11:16 EDTNVAXNovavax to host analyst and investor day
Subscribe for More Information
07:32 EDTPMKM Partners to hold a conference
Subscribe for More Information
06:05 EDTTEFAmazon partners with Bango, Telefonica Deutschland on carrier billing services
Subscribe for More Information
September 17, 2014
11:47 EDTPStocks with call strike movement; PBR P
Subscribe for More Information
11:47 EDTSKULSkullcandy management to meet with Roth Capital
Subscribe for More Information
10:00 EDTSKULOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AB InBev (BUD) upgraded to Hold from Sell at Societe Generale... Baker Hughes (BHI) upgraded to Outperform from Sector Perform at Howard Weil... Bank of the Ozarks (OZRK) upgraded to Buy from Hold at BB&T... Bill Barrett (BBG) upgraded to Buy from Neutral at Mizuho... Cepheid (CPHD) upgraded to Buy from Hold at Cantor... Cigna (CI) upgraded to Positive from Neutral at Susquehanna... Extra Space Storage (EXR) upgraded to Buy from Hold at Jefferies... GNC Holdings (GNC) upgraded to Outperform from Neutral at Wedbush... MB Financial (MBFI) upgraded at DA Davidson... Mondelez (MDLZ) upgraded to Buy from Hold at Societe Generale... Radian Group (RDN) upgraded to Buy from Neutral at Compass Point... Skullcandy (SKUL) assumed with a Overweight from Neutral at Piper Jaffray... Under Armour (UA) upgraded to Overweight from Neutral at Piper Jaffray.
09:22 EDTTEFTelecom Italia not holding talks with Oi, Tim Participacoes says,Reuters reports
Subscribe for More Information
06:52 EDTSKULSkullcandy assumed with a Overweight from Neutral at Piper Jaffray
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use